Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer Journal Article


Authors: Franiel, T.; Hamm, B.; Hricak, H.
Article Title: Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer
Abstract: Dynamic contrast-enhanced MRI enables noninvasive analysis of prostate vascularization as well as tumour angiogenesis and capillary permeability characteristics in prostate cancers. Pharmacokinetic models summarizing the complex information provided by signal intensity-time curves for a few quantitative pharmacokinetic parameters are increasingly being used in the routine clinical setting. This review consists of two parts. The first part discusses the advantages and disadvantages of the MR pulse sequences that can be used for performing DCE-MRI and also of the most widely used pharmacokinetic parameters and models and the parameters they describe. The second part outlines the range of current and potential future clinical applications of DCE-MRI and pharmacokinetic parametric maps in patients with prostate cancer, with reference to the current scientific literature on the topic. The potential clinical applications of DCE-MRI for prostate cancer include detection, localization, and staging, differentiation of recurrent cancer and estimation of the patient's prognosis, as well as monitoring of treatment response. © 2010 European Society of Radiology.
Keywords: prostate; blood flow; dce-mri; permeability; pharmacokinetic parameters
Journal Title: European Radiology
Volume: 21
Issue: 3
ISSN: 0938-7994
Publisher: Springer  
Date Published: 2011-03-01
Start Page: 616
End Page: 626
Language: English
DOI: 10.1007/s00330-010-2037-7
PROVIDER: scopus
PUBMED: 21184082
DOI/URL:
Notes: --- - "Export Date: 4 March 2011" - "CODEN: EURAE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Hedvig Hricak
    421 Hricak